From Name

From Email

To Name

To Email

Message

Surgery for metastatic breast cancer fails to boost overall survival

from MedPage Today

Surgery for metastatic breast cancer fails to boost overall survival MedPage Today Local treatment of a primary tumor did not improve survival for women with de novo metastatic breast cancer, results of a randomized trial showed. After a median follow-up of 53 months, median survival for all 256 randomized patients was 54 months and did not differ between the patients who received systemic therapy only and those who received systemic therapy and local treatment (surgery with or without radiation therapy) of the primary tumor. READ MORE

more